Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0523
+0.0003 (0.58%)
Mar 5, 2026, 12:34 PM EST

PVCT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
225040452323
Market Cap Growth
-49.95%25.33%-11.35%96.93%-1.55%-5.21%
Enterprise Value
245343482346
Last Close Price
0.050.120.100.110.060.06
PS Ratio
62.9681.7972.2145.94--
PB Ratio
-3.58-8.46-5.30-7.29-5.51-0.78
EV/Sales Ratio
69.7286.0577.2548.64--
Debt / Equity Ratio
-0.40-0.53-0.40-0.35-0.42-0.79
Net Debt / Equity Ratio
-0.38-0.48-0.39-0.35-0.25-0.78
Net Debt / EBITDA Ratio
-0.39-0.73-1.18-0.76-0.23-5.05
Net Debt / FCF Ratio
-0.70-0.88-1.15-0.71-1.05-5.80
Asset Turnover
0.570.500.320.36--
Quick Ratio
0.010.040.010.000.090.00
Current Ratio
0.040.140.150.230.450.01
Return on Assets (ROA)
-623.13%-200.92%-89.58%-64.62%-141.40%-298.62%
Return on Capital Employed (ROCE)
100.70%66.10%33.00%46.60%110.80%16.40%
Earnings Yield
-30.20%-9.44%-7.70%-7.82%-24.01%-28.50%
FCF Yield
--6.51%-6.39%-6.69%-4.39%-17.44%
Buyback Yield / Dilution
-0.16%-0.07%-0.01%-2.76%-3.81%-1.72%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.